FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
about
Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical RelevanceThe Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.Scaffold-free generation of uniform adipose spheroids for metabolism research and drug discovery.FGF 21 deficiency slows gastric emptying and reduces initial blood alcohol concentration in mice exposed to acute alcohol in fasting state.PCB126 inhibits the activation of AMPK-CREB signal transduction required for energy sensing in liver.Defining “FGF21 Resistance” during obesity: Controversy, criteria and unresolved questions.
P2860
FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
@en
FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
@nl
type
label
FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
@en
FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
@nl
prefLabel
FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
@en
FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
@nl
P2860
P356
P1476
FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology.
@en
P2093
Matthew J Potthoff
P2860
P2888
P356
10.1038/NRENDO.2016.206
P577
2016-12-16T00:00:00Z